Shenzhen Salubris Pharmaceuticals A Logo

Shenzhen Salubris Pharmaceuticals A

🇨🇳
002294
CNE100000FW8

Shenzhen Salubris Pharmaceuticals A is a leading Chinese biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines. Its primary focus lies in cardiovascular diseases, oncology, and diabetes to improve global healthcare outcomes and patient wellbeing.

Next Quarterly Earnings

Tuesday, October 27, 2026
CW 44
Pre-Market
In 61 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on September 29, 2026

Stock Price

Frequently asked questions

When will Shenzhen Salubris Pharmaceuticals A report its next quarterly earnings?

Shenzhen Salubris Pharmaceuticals A is scheduled to report its next quarterly earnings on 10/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Shenzhen Salubris Pharmaceuticals A last report quarterly earnings?

Shenzhen Salubris Pharmaceuticals A last reported quarterly earnings on 8/25/2026 (Q2 2026).

How do I add the Shenzhen Salubris Pharmaceuticals A earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:
Actual:
Q2 2026
Estimate:
Actual:
Q1 2026
Missed
Estimate:CN¥0.60
Actual:CN¥0.58
Difference:-CN¥0.02
Price reaction (1 day):-2.8 %
Price reaction (7 days):-5.5 %

Company Information

Name
Shenzhen Salubris Pharmaceuticals A
Ticker Symbol
002294
ISIN
CNE100000FW8
Country
🇨🇳
China
Sector